Immuneering Corp - IMRX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jan 22, 2026 | SCHEDULE 13G/A | BENJAMIN J. ZESKIND | 6.6% | 4,357,807 | View |
| Jan 15, 2026 | SCHEDULE 13G/A | Empery Asset Management, LP | 4.99% | 3,250,775 | View |
| Jan 15, 2026 | SCHEDULE 13G/A | Ryan M. Lane | 4.99% | 3,250,775 | View |
| Oct 21, 2025 | SCHEDULE 13G | Empery Asset Management, LP | 8.83% | 5,188,755 | View |
| Oct 21, 2025 | SCHEDULE 13G | Ryan M. Lane | 8.83% | 5,188,755 | View |
| Oct 21, 2025 | SCHEDULE 13G | Martin D. Hoe | 8.83% | 5,188,755 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.